FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for sirolimus submitted by Mylan Pharmaceuticals Inc., updating the drug's status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant
• Kidney Transplant
• Liver Transplant

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

SUPPL AP for SIROLIMUS (SIROLIMUS)